Leef Brands Inc. Announces Preferred Share Financing to Fund Processing Facility

What Happened Leef Brands Inc. (LEEEF) filed an 8-K reporting a closing of a non-brokered private placement and share exchange for Series A-2 preferred shares. The company issued 33,401,551 Series A-2 Preferred Shares in total: 20,800,000 sold for new cash at US$0.25 each (gross proceeds US$5,200,000) and 12,601,551 issued in exchange for surrender/cancellation of 11,204,376 Series A-1 preferred shares plus supplemental dividends covering June 1, 2026–July 10, 2026. Each Series A-2 Preferred Share is convertible into common shares at US$0.25 per share (subject to customary anti-dilution adjustments). Including prior closings, Leef has raised about US$14.5 million from its preferred share offering. The company issued a press release on July 27, 2026 about these matters.

Key Details

• Total Series A-2 issued at this closing: 33,401,551 shares (20,800,000 for cash; 12,601,551 by exchange).
• Cash raised at this closing: US$5,200,000 (US$0.25 per Series A-2 share). Aggregate offering proceeds to date: ~US$14,500,000.
• Conversion: Series A-2 convertible to common shares at US$0.25 per share, with customary anti-dilution protections.
• Purpose: Net proceeds intended to fund acquisition of a processing facility (drying, curing, freezing, storage) to handle biomass from Salisbury Canyon Ranch before extraction at LEEF Labs (Mendocino County). Facility expected to support a 180‑acre cultivation footprint and enable third‑party processing/storage revenue and future interstate/international operations.
• Related party: Insider Robert J. Mendola Jr. participated in the exchange; company relied on exemptions under MI 61-101 (no formal valuation or minority shareholder approval).
• Securities were issued under exemptions from U.S. registration (not registered under the Securities Act) and are subject to transfer restrictions.

Why It Matters This filing shows Leef Brands is raising capital and converting prior preferred shares to support a strategic, near-term investment in a processing facility intended to serve its cultivation and extraction operations. For investors, the financing and conversion terms (US$0.25 conversion price) affect potential dilution and the company’s cash runway and growth plans. The related-party participation and reliance on regulatory exemptions are disclosed risks and governance points investors may want to note.